NORTHERN IRELAND

• Recognized for its Patient Centric Solutions and State-of-the-Art Technology, the Medical-Grade Cumulus EEG Headset Wins Third Award in 2023 for Innovative Design While Advancing Clinical Neuroscience Research
  BELFAST, Northern Ireland and CAMBRIDGE, Mass., Feb. 7, 2024 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, has been recognized by GOOD DESIGN® Awards , in the medical category for the product design of its first-in-class electroencephalogram (EEG) headset.
• The headset synchronizes with tablet-based functional assessments for use in-clinic or unsupervised (at-home/remote) environments, allowing for increased ease-of-use for patients, caregivers, and clinical research teams.
• The GOOD DESIGN® Award is the oldest and most prestigious awards program for the most innovative and cutting-edge industrial, product, and graphic designs produced around the world.
• The Cumulus Neuroassessment Platform, which includes our EEG headset, removes those barriers entirely.

• Cancer cell DNA uracilation by CV6-168 is aided by combination with standard cancer therapies including thymidylate synthase (TS) inhibitors such as 5-fluorouracil (5-FU).
• The UK multi-centre Phase 1a clinical trial will combine CV6-168 with infusional 5-FU to treat gastrointestinal cancer patients, such as colon, gastric, and pancreatic cancers as well as other tumor types such as melanoma, lung, and ovarian cancers.
• The trial is expected to have dosed its first patient in Q1 2024, with trial read-outs expected in H1 2025.
• CV6 CEO and Founder Dr Robert Ladner said, “This regulatory approval is a key milestone as we progress CV6-168 into a first-in-human Phase 1a clinical trial.

• The Great Place to Work® Certification™ is a significant achievement, signifying the company's commitment to fostering a positive workplace culture.
• As well as obtaining certification as a Great Place to Work UK for the second year in a row, Learning Pool has also received accreditation in the US in recognition of its global operations.
• "We are thrilled to be Great Place to Work-Certified for the second year," says Learning Pool's CHRO, Louise McElvaney.
• "We congratulate Learning Pool on achieving their Certification™ for the second time," said Benedict Gautrey, Managing Director of Great Place to Work® UK.

• Political pundits reacting to the speech on the BBC immediately questioned the rationale behind potentially putting more people in prison, when UK prisons are struggling to accommodate those already under their purview.
• The England and Wales prison watchdog has said that one in ten prisons in those two countries should be shut down because of overcrowding and inhumane regimes.
• And in September 2023 a German court in Karlsruhe followed suit, refusing to extradite a man to the UK.

The UK’s high rates of imprisonment

• British rates of imprisonment are among the highest in western Europe.
• Imprisonment rates have been climbing in England and Wales over the last 30 years, as well as in Scotland with rates described as “stubbornly high” by criminologists.
• In Northern Ireland, historically, rates of imprisonment have been closer to those in the Republic of Ireland.

How incarceration impacts prisoners, families and society

• They increase people’s risk of coming to physical harm, with rising tensions and inadequate staffing to de-escalate and respond.
• For prison staff, overcrowding intensifies an inherently complex and demanding job.
• Our research shows that the wider impact of bad prison conditions is felt by the families of loved ones in custody – and society at large.
• This in turn also adds pressure to household budgets however, for example with travel costs associated with prison visits.
• Truly addressing overcrowding has to start with reducing the number of people sent to prison in the first place.

Rebecca Foster has previously received funding from the Dawes Trust, the Scottish Government, and the Scottish Centre for Crime and Justice Research. Kirstin Anderson previously received funding from the Scottish Government, Royal Society of Edinburgh, the British Academy and the Scottish Centre for Crime and Justice Research.